Coinpaper
AstraZeneca Stock Falls While BMY Stock Jumps on Merger Talks
BMY stock climbed while AstraZeneca stock dropped after reports of merger talks that could create a nearly $400 billion drugmaker.
Read the full article on Coinpaper
Opens in a new tab. Cointrackx tracks this click for statistics.
Partner
